XBRU
AED
Market cap3.77bUSD
Sep 17, Last price
66.05EUR
1D
0.00%
1Q
-3.15%
Jan 2017
-0.36%
IPO
98.67%
Name
Aedifica NV
Chart & performance
P/E
13.44
P/S
8.88
EPS
4.91
Div yield, %
5.90%
Shrs. gr., 5y
11.08%
Rev. gr., 5y
14.15%
Revenues
370m
+6.46%
Net income
244m
+19.33%
CFO
263m
+5.65%
Dividend
May 14, 20264 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Aedifica, a publicly traded Belgian company, specializes in providing sustainable property solutions to professional care operators across Europe. Its primary focus is on investing in high-quality European healthcare real estate, particularly facilities designed for the elderly. Having established itself as a significant leader in the European listed real estate sector in recent years, Aedifica aims to further solidify this position in the foreseeable future. The company's investment strategy centres on acquiring premium buildings that generate consistent, inflation-adjusted rental income and offer opportunities for capital growth, thereby ensuring its shareholders benefit from a reliable, long-term real estate investment with an attractive return. Aedifica has been listed on Euronext Brussels since 2006 and Euronext Amsterdam since 2019, and as of March 2020, it is also a component of the BEL 20, Euronext Brussels' leading stock market index.
Related entities
Subsidiaries
AEDIFICA UK LIMITED
Key people
Ingrid Daerden
Chief Financial Officer, Member of the Management Board · since 2018
Sven Bogaerts
Chief Mergers and Acquisitions Officers, Executive Director · since 2017
Eric Hohl
Non-Executive Director · since 2014
Adeline Simont
Non-Executive Director · since 2005
Elisabeth May-Roberti
Non-Executive Independent Director · since 2015
Luc Plasman
Non-Executive Independent Director · since 2017
Headquarters & legal address
Belliardstraat 40, bus 11
Etterbeek, BRU 1040
BE
Etterbeek, BRU 1040
BE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||